Atrioventricular canal defect in patients with RASopathies

Maria Cristina Digilio, Francesca Romana Lepri, Maria Lisa Dentici, Alex Henderson, Anwar Baban, Maria Cristina Roberti, Rossella Capolino, Paolo Versacci, Cecilia Surace, Adriano Angioni, Marco Tartaglia, Bruno Marino, Bruno Dallapiccola

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Congenital heart defects affect 60-85% of patients with RASopathies. We analysed the clinical and molecular characteristics of atrioventricular canal defect in patients with mutations affecting genes coding for proteins with role in the RAS/MAPK pathway. Between 2002 and 2011, 101 patients with cardiac defect and a molecularly confirmed RASopathy were collected. Congenital heart defects within the spectrum of complete or partial (including cleft mitral valve) atrioventricular canal defect were diagnosed in 8/101 (8%) patients, including seven with a PTPN11 gene mutation, and one single subject with a RAF1 gene mutation. The only recurrent mutation was the missense PTPN11 c.124 A>G change (T42A) in PTPN11. Partial atrioventricular canal defect was found in six cases, complete in one, cleft mitral valve in one. In four subjects the defect was associated with other cardiac defects, including subvalvular aortic stenosis, mitral valve anomaly, pulmonary valve stenosis and hypertrophic cardiomyopathy. Maternal segregation of PTPN11 and RAF1 gene mutations occurred in two and one patients, respectively. Congenital heart defects in the affected relatives were discordant in the families with PTPN11 mutations, and concordant in that with RAF1 mutation. In conclusion, our data confirm previous reports indicating that atrioventricular canal defect represents a relatively common feature in Noonan syndrome. Among RASopathies, atrioventricular canal defect was observed to occur with higher prevalence among subjects with PTPN11 mutations, even though this association was not significant possibly because of low statistical power. Familial segregation of atrioventricular canal defect should be considered in the genetic counselling of families with RASopathies.

Original languageEnglish
Pages (from-to)200-204
Number of pages5
JournalEuropean Journal of Human Genetics
Volume21
Issue number2
DOIs
Publication statusPublished - Feb 2013

Fingerprint

Mutation
Congenital Heart Defects
Mitral Valve
Subvalvular Aortic Stenosis
Noonan Syndrome
Genes
Pulmonary Valve Stenosis
Hypertrophic Cardiomyopathy
Genetic Counseling
Missense Mutation
Atrioventricular Septal Defect
Mothers
Proteins

Keywords

  • atrioventricular canal defect
  • Noonan syndrome
  • PTPN11 gene
  • RAF1 gene
  • RAS/MAPK pathway

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

Atrioventricular canal defect in patients with RASopathies. / Digilio, Maria Cristina; Romana Lepri, Francesca; Lisa Dentici, Maria; Henderson, Alex; Baban, Anwar; Cristina Roberti, Maria; Capolino, Rossella; Versacci, Paolo; Surace, Cecilia; Angioni, Adriano; Tartaglia, Marco; Marino, Bruno; Dallapiccola, Bruno.

In: European Journal of Human Genetics, Vol. 21, No. 2, 02.2013, p. 200-204.

Research output: Contribution to journalArticle

@article{68c05d85c1644b9a8db6660721b984f6,
title = "Atrioventricular canal defect in patients with RASopathies",
abstract = "Congenital heart defects affect 60-85{\%} of patients with RASopathies. We analysed the clinical and molecular characteristics of atrioventricular canal defect in patients with mutations affecting genes coding for proteins with role in the RAS/MAPK pathway. Between 2002 and 2011, 101 patients with cardiac defect and a molecularly confirmed RASopathy were collected. Congenital heart defects within the spectrum of complete or partial (including cleft mitral valve) atrioventricular canal defect were diagnosed in 8/101 (8{\%}) patients, including seven with a PTPN11 gene mutation, and one single subject with a RAF1 gene mutation. The only recurrent mutation was the missense PTPN11 c.124 A>G change (T42A) in PTPN11. Partial atrioventricular canal defect was found in six cases, complete in one, cleft mitral valve in one. In four subjects the defect was associated with other cardiac defects, including subvalvular aortic stenosis, mitral valve anomaly, pulmonary valve stenosis and hypertrophic cardiomyopathy. Maternal segregation of PTPN11 and RAF1 gene mutations occurred in two and one patients, respectively. Congenital heart defects in the affected relatives were discordant in the families with PTPN11 mutations, and concordant in that with RAF1 mutation. In conclusion, our data confirm previous reports indicating that atrioventricular canal defect represents a relatively common feature in Noonan syndrome. Among RASopathies, atrioventricular canal defect was observed to occur with higher prevalence among subjects with PTPN11 mutations, even though this association was not significant possibly because of low statistical power. Familial segregation of atrioventricular canal defect should be considered in the genetic counselling of families with RASopathies.",
keywords = "atrioventricular canal defect, Noonan syndrome, PTPN11 gene, RAF1 gene, RAS/MAPK pathway",
author = "Digilio, {Maria Cristina} and {Romana Lepri}, Francesca and {Lisa Dentici}, Maria and Alex Henderson and Anwar Baban and {Cristina Roberti}, Maria and Rossella Capolino and Paolo Versacci and Cecilia Surace and Adriano Angioni and Marco Tartaglia and Bruno Marino and Bruno Dallapiccola",
year = "2013",
month = "2",
doi = "10.1038/ejhg.2012.145",
language = "English",
volume = "21",
pages = "200--204",
journal = "European Journal of Human Genetics",
issn = "1018-4813",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Atrioventricular canal defect in patients with RASopathies

AU - Digilio, Maria Cristina

AU - Romana Lepri, Francesca

AU - Lisa Dentici, Maria

AU - Henderson, Alex

AU - Baban, Anwar

AU - Cristina Roberti, Maria

AU - Capolino, Rossella

AU - Versacci, Paolo

AU - Surace, Cecilia

AU - Angioni, Adriano

AU - Tartaglia, Marco

AU - Marino, Bruno

AU - Dallapiccola, Bruno

PY - 2013/2

Y1 - 2013/2

N2 - Congenital heart defects affect 60-85% of patients with RASopathies. We analysed the clinical and molecular characteristics of atrioventricular canal defect in patients with mutations affecting genes coding for proteins with role in the RAS/MAPK pathway. Between 2002 and 2011, 101 patients with cardiac defect and a molecularly confirmed RASopathy were collected. Congenital heart defects within the spectrum of complete or partial (including cleft mitral valve) atrioventricular canal defect were diagnosed in 8/101 (8%) patients, including seven with a PTPN11 gene mutation, and one single subject with a RAF1 gene mutation. The only recurrent mutation was the missense PTPN11 c.124 A>G change (T42A) in PTPN11. Partial atrioventricular canal defect was found in six cases, complete in one, cleft mitral valve in one. In four subjects the defect was associated with other cardiac defects, including subvalvular aortic stenosis, mitral valve anomaly, pulmonary valve stenosis and hypertrophic cardiomyopathy. Maternal segregation of PTPN11 and RAF1 gene mutations occurred in two and one patients, respectively. Congenital heart defects in the affected relatives were discordant in the families with PTPN11 mutations, and concordant in that with RAF1 mutation. In conclusion, our data confirm previous reports indicating that atrioventricular canal defect represents a relatively common feature in Noonan syndrome. Among RASopathies, atrioventricular canal defect was observed to occur with higher prevalence among subjects with PTPN11 mutations, even though this association was not significant possibly because of low statistical power. Familial segregation of atrioventricular canal defect should be considered in the genetic counselling of families with RASopathies.

AB - Congenital heart defects affect 60-85% of patients with RASopathies. We analysed the clinical and molecular characteristics of atrioventricular canal defect in patients with mutations affecting genes coding for proteins with role in the RAS/MAPK pathway. Between 2002 and 2011, 101 patients with cardiac defect and a molecularly confirmed RASopathy were collected. Congenital heart defects within the spectrum of complete or partial (including cleft mitral valve) atrioventricular canal defect were diagnosed in 8/101 (8%) patients, including seven with a PTPN11 gene mutation, and one single subject with a RAF1 gene mutation. The only recurrent mutation was the missense PTPN11 c.124 A>G change (T42A) in PTPN11. Partial atrioventricular canal defect was found in six cases, complete in one, cleft mitral valve in one. In four subjects the defect was associated with other cardiac defects, including subvalvular aortic stenosis, mitral valve anomaly, pulmonary valve stenosis and hypertrophic cardiomyopathy. Maternal segregation of PTPN11 and RAF1 gene mutations occurred in two and one patients, respectively. Congenital heart defects in the affected relatives were discordant in the families with PTPN11 mutations, and concordant in that with RAF1 mutation. In conclusion, our data confirm previous reports indicating that atrioventricular canal defect represents a relatively common feature in Noonan syndrome. Among RASopathies, atrioventricular canal defect was observed to occur with higher prevalence among subjects with PTPN11 mutations, even though this association was not significant possibly because of low statistical power. Familial segregation of atrioventricular canal defect should be considered in the genetic counselling of families with RASopathies.

KW - atrioventricular canal defect

KW - Noonan syndrome

KW - PTPN11 gene

KW - RAF1 gene

KW - RAS/MAPK pathway

UR - http://www.scopus.com/inward/record.url?scp=84872498338&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872498338&partnerID=8YFLogxK

U2 - 10.1038/ejhg.2012.145

DO - 10.1038/ejhg.2012.145

M3 - Article

VL - 21

SP - 200

EP - 204

JO - European Journal of Human Genetics

JF - European Journal of Human Genetics

SN - 1018-4813

IS - 2

ER -